Skopos Labs, Inc. Acadia Pharmaceuticals Inc Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 396 shares of ACAD stock, worth $8,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
396
Previous 188
110.64%
Holding current value
$8,450
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$915 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$324 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$257 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$182 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$149 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.45B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...